Meta Platforms (META, Financials) reported fourth-quarter 2024 earnings that exceeded expectations, driven by strong ...

IBM stock has risen by 22 percent over the past year, with shares rising by nine percent on the morning following the ...

Brunswick Corp (NYSE:BC) reported fourth-quarter financial results before the market open on Thursday. Here's a rundown of the report.

CARGO elects to discontinue FIRCE-1, a Phase 2 clinical study of firicabtagene autoleucel (firi-cel)1; Company believes results do not support a ...

TER's fourth-quarter 2024 results benefit from strong momentum in the memory test end market and increased compute demand for ...

Immunome's varegacestat is in a phase 3 trial in patients with desmoid tumors that should produce results in H2'25. Read why ...

CAR T–focused biotech Cargo Therapeutics surprised and disappointed analysts when it announced that it would discontinue a mid-stage trial of its lead program, firi-cel.

Meta witnessed a 49% year-on-year growth in profit in Q4 2024; ad revenue grew 21% despite changes easing content moderation.

Silicom aims to achieve 7–9 additional design wins in 2025, which are expected to play a pivotal role in long-term revenue growth. Management reiterated their strategic goal of reaching annual ...

US social media giant Meta Platforms Inc on Wednesday reported financial results for the quarter and full year ending Dec 31 2024 with a total ...

After a nearly $300 million IPO little more than a year ago, a young Peninsula biotech company will discontinue what had been ...

CARGO Therapeutic announced that it has elected to discontinue FIRCE-1, a Phase 2 clinical study of firi-cel for patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 ...